Pharmaron Beijing Co Ltd logo

Pharmaron Beijing Co Ltd

PHBBF · OTC · Biotech · Founded 2004

Pharmaron Beijing Co., Ltd. engages in the provision of full-process integrated drug research, development, and production services from drug discovery to drug development. It provides laboratory, CMC, macromolecules and cell & gene therapy, and clinical research services.

Current Price
—
Market Cap
—
Return Since Last Split
+24%
Last Split
Jul 27, 2023
Total Splits
2
Cumulative Multiple
2.25×

What If You Bought PHBBF Earlier?

Investment
Purchase Date (Before Split)
Worth Today
—
225 shares · 2×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.

Split DatePrice BeforeRatioSplit MultipleCumulative
Jul 27, 2023—3-for-21.5×2.25×
Jun 14, 2022—3-for-21.5×1.5×

Pharmaron Beijing Co Ltd Market Cap Timeline

A validated annual market-cap history is unavailable from the current sources. The current market-cap snapshot, when shown above, is not treated as historical evidence. Split markers cover 2 current-security splits. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Validated annual history unavailable

At least two source-validated annual observations are required before this page draws a market-cap timeline. A current snapshot is not treated as historical trend data.

Recorded split dates

Frequently Asked Questions

Pharmaron Beijing Co Ltd's latest record in the split calendar is a 3-for-2 forward split effective 2023-07-27.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.